🚀 VC round data is live in beta, check it out!
COSMAX Valuation Multiples
Discover revenue and EBITDA valuation multiples for COSMAX and similar public comparables like Perrigo, Amorepacific Group, Faes Farma, Harbin Fuerjia Technology and more.
COSMAX Overview
About COSMAX
Cosmax Inc is a Korean-based specialized cosmetics research and development and manufacturing company. COSMAX develops and provides cosmetics to more than 600 cosmetics brands around the world. The key product consists of skincare, makeup, mask sheets, oriental medicine, haircare, functional cosmetics, and scents. Its products are also sold in Europe, North America, and Central and South America. The company also has four corporations in Shanghai and Guangzhou, China, Indonesia, and the United States.
Founded
1992
HQ
Employees
280
Website
Sectors
Financials (LTM)
EV
$2B
COSMAX Financials
COSMAX reported last 12-month revenue of $2B and EBITDA of $192M.
In the same LTM period, COSMAX generated $293M in gross profit, $192M in EBITDA, and $86M in net income.
Revenue (LTM)
COSMAX P&L
In the most recent fiscal year, COSMAX reported revenue of $2B and EBITDA of $189M.
COSMAX expects next 12-month revenue of XXX and NTM EBITDA of XXX
| LTM | NTM | Last FY | FY 2026 | FY 2027 | FY 2028 | |
|---|---|---|---|---|---|---|
| Revenue | $2B | XXX | $2B | XXX | XXX | XXX |
| Gross Profit | $293M | XXX | $279M | XXX | XXX | XXX |
| Gross Margin | 17% | XXX | 17% | XXX | XXX | XXX |
| EBITDA | $192M | XXX | $189M | XXX | XXX | XXX |
| EBITDA Margin | 11% | XXX | 12% | XXX | XXX | XXX |
| EBIT Margin | 8% | XXX | 8% | XXX | XXX | XXX |
| Net Profit | $86M | XXX | $84M | XXX | XXX | XXX |
| Net Margin | 5% | XXX | 5% | XXX | XXX | XXX |
| Net Debt | — | — | $400M | XXX | XXX | XXX |
Financial data powered by Morningstar, Inc.
COSMAX Stock Performance
COSMAX has current market cap of $2B, and enterprise value of $2B.
Market Cap Evolution
COSMAX's stock price is $144.46.
| EV | Market Cap | Price 1D | Price 1M | Price 3M | Price 12M | EPS |
|---|---|---|---|---|---|---|
| $2B | $2B | 0.0% | XXX | XXX | XXX | $7.40 |
Benchmark Trading Valuation Multiples by Industry
Sign up to access valuation multiples like growth-adjusted P/E, Rule of 40, next 12-month EV/Revenue, EBITDA multiples by industry, consensus analyst estimates and many more.
Start Free TrialCOSMAX Valuation Multiples
COSMAX trades at 1.2x EV/Revenue multiple, and 10.6x EV/EBITDA.
EV / Revenue (LTM)
COSMAX Financial Valuation Multiples
As of April 19, 2026, COSMAX has market cap of $2B and EV of $2B.
Equity research analysts estimate COSMAX's 2025E EV/Revenue multiple at XXX and 2025E EV/EBITDA multiple at XXX
COSMAX has a P/E ratio of 19.0x.
| LTM | NTM | Last FY | FY 2026 | FY 2027 | FY 2028 | |
|---|---|---|---|---|---|---|
| Market cap (current) | $2B | XXX | $2B | XXX | XXX | XXX |
| EV (current) | $2B | XXX | $2B | XXX | XXX | XXX |
| EV/Revenue | 1.2x | XXX | 1.3x | XXX | XXX | XXX |
| EV/EBITDA | 10.6x | XXX | 10.8x | XXX | XXX | XXX |
| EV/EBIT | 14.7x | XXX | 15.3x | XXX | XXX | XXX |
| EV/Gross Profit | 7.0x | XXX | 7.3x | XXX | XXX | XXX |
| P/E | 19.0x | XXX | 19.5x | XXX | XXX | XXX |
| EV/FCF | (549.5x) | XXX | (61.7x) | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Verified COSMAX Valuation Multiples
Access all public comps and forward-looking valuation multiples like EV/Revenue in 2027, based on consensus analyst estimates. Powered by FactSet and Morningstar.
COSMAX Margins & Growth Rates
COSMAX's revenue in the last 12 month grew by 13%.
COSMAX's revenue per employee in the last FY averaged $5.8M, while opex per employee averaged $0.5M for the same period.
COSMAX's rule of 40 is 24% (metric relevant for SaaS companies only, counted as combined revenue growth rate and EBITDA margin).
COSMAX's rule of X is 42% (created by Bessemer, rule of X is another metric to measure SaaS companies, ~1.5x stronger vs. the traditional Rule of 40, counted as revenue growth rate multiplied by 2.5 plus EBITDA margin).
COSMAX Operational Valuation Multiples
| LTM | NTM | Last FY | FY 2026 | FY 2027 | FY 2028 | |
|---|---|---|---|---|---|---|
| Revenue Growth | 13% | XXX | 12% | XXX | XXX | XXX |
| EBITDA Margin | 11% | XXX | 12% | XXX | XXX | XXX |
| EBITDA Growth | 17% | XXX | 14% | XXX | XXX | XXX |
| Rule of 40 | — | XXX | 24% | XXX | XXX | XXX |
| Bessemer Rule of X | — | XXX | 42% | XXX | XXX | XXX |
| Revenue per Employee | — | XXX | $5.8M | XXX | XXX | XXX |
| Opex per Employee | — | XXX | $0.5M | XXX | XXX | XXX |
| S&M Expenses to Revenue | 3% | XXX | 4% | XXX | XXX | XXX |
| G&A Expenses to Revenue | — | XXX | 1% | XXX | XXX | XXX |
| R&D Expenses to Revenue | — | XXX | 0% | XXX | XXX | XXX |
| Opex to Revenue | — | XXX | 9% | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc. and Morningstar, Inc.
COSMAX Public Comps
See public comps and valuation multiples for other Health & Beauty comps.
| EV/Revenue | EV/EBITDA | |||||
|---|---|---|---|---|---|---|
| LTM | 2026E | 2027E | LTM | 2026E | 2027E | |
| COSMAX | XXX | XXX | XXX | XXX | XXX | XXX |
| Perrigo | XXX | XXX | XXX | XXX | XXX | XXX |
| Amorepacific Group | XXX | XXX | XXX | XXX | XXX | XXX |
| Faes Farma | XXX | XXX | XXX | XXX | XXX | XXX |
| Harbin Fuerjia Technology | XXX | XXX | XXX | XXX | XXX | XXX |
| Kolmar Korea | XXX | XXX | XXX | XXX | XXX | XXX |
| XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
| XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc.
COSMAX M&A Activity
COSMAX acquired XXX companies to date.
Last acquisition by COSMAX was on XXXXXXXX, XXXXX. COSMAX acquired XXXXXXXX for XXX (EV/Revenue multiple of XXX).
Latest Acquisitions by COSMAX
| Acquired Company | Valuation | EV/Revenue | EV/EBITDA |
|---|---|---|---|
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
Get Verified M&A Valuation Multiples
Sign up to see revenue and EBITDA valuation multiples for 150K+ M&A deals.
Start Free TrialCOSMAX Investment Activity
COSMAX invested in XXX companies to date.
COSMAX made its latest investment on XXXXXXXX, XXXXX. COSMAX invested in XXXXXXXX for XXX (EV/Revenue multiple of XXX).
Latest Investments by COSMAX
| Company | Valuation | EV/Revenue | EV/EBITDA |
|---|---|---|---|
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
Benchmark 350K+ Funding Rounds and Disclosed VC Valuation Multiples
Sign up to see data on 350K+ funding rounds and disclosed revenue and EBITDA valuation multiples, from seed, through growth stage, to pre-IPO.
Start Free TrialAbout COSMAX
| When was COSMAX founded? | COSMAX was founded in 1992. |
| Where is COSMAX headquartered? | COSMAX is headquartered in South Korea. |
| How many employees does COSMAX have? | As of today, COSMAX has over 280 employees. |
| Who is the CEO of COSMAX? | COSMAX's CEO is Byung-man Lee. |
| Is COSMAX publicly listed? | Yes, COSMAX is a public company listed on Korea Exchange. |
| What is the stock symbol of COSMAX? | COSMAX trades under 192820 ticker. |
| When did COSMAX go public? | COSMAX went public in 2014. |
| Who are competitors of COSMAX? | COSMAX main competitors are Perrigo, Amorepacific Group, Faes Farma, Harbin Fuerjia Technology. |
| What is the current market cap of COSMAX? | COSMAX's current market cap is $2B. |
| What is the current revenue of COSMAX? | COSMAX's last 12 months revenue is $2B. |
| What is the current revenue growth of COSMAX? | COSMAX revenue growth (NTM/LTM) is 13%. |
| What is the current EV/Revenue multiple of COSMAX? | Current revenue multiple of COSMAX is 1.2x. |
| Is COSMAX profitable? | Yes, COSMAX is EBITDA-positive (as of the last 12 months). |
| What is the current EBITDA of COSMAX? | COSMAX's last 12 months EBITDA is $192M. |
| What is COSMAX's EBITDA margin? | COSMAX's last 12 months EBITDA margin is 11%. |
| What is the current EV/EBITDA multiple of COSMAX? | Current EBITDA multiple of COSMAX is 10.6x. |
| What is the current FCF of COSMAX? | COSMAX's last 12 months FCF is ($4M). |
| What is COSMAX's FCF margin? | COSMAX's last 12 months FCF margin is (0%). |
| What is the current EV/FCF multiple of COSMAX? | Current FCF multiple of COSMAX is (549.5x). |
Start Your
Free Trial Today
Try Multiples for free for 3 days. Got questions or need a demo? Schedule a call with us below.